# 



## 

## 

|||Page|
|---|---|---|
|Reference and administrative<br>details ofthe company,|its Trustees and advisers|1-2|
|Trustees'<br>report||3-6|
|Independent<br>examiner's<br>report|||
|Statement offinancial activities|||
|Income and expenditure<br>account|||
|Balance sheet||10-11|
|Notes to the financial statements||12-21|





|Company|registered|||
|---|---|---|---|
|number||3438264||
|Charity registered||||
|number||1066856||
|Registered|office|Clinical Trials Research|Unit|
|||University<br>ofLeeds||
|||Leeds||
|||West Yorkshire||
|||LS29JT||
|Chief executive officer||Dimitri Beeckman||
|Accountants||Birgitte ToffAccountancy|Limited|
|||Accountants||
|||29Tweedy Street||
|||Wilsden||
|||Bradford||
|||West Yorkshire||
|||BD15OAE||
|Bankers||Natwest<br>Bank||
|||Keighley<br>(A) Branch||
|||63 North Street||
|||Keighley||
|||West Yorkshire||
|||BD21 3SB||





## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 



## 

|||Unrestricted|Total|Total|
|---|---|---|---|---|
|||funds|funds|funds|
|||2021|2021|2020|
||Note|F|f.||
|Income from:|||||
|Donations<br>and legacies<br>Other trading<br>activities||19,884<br>57,085|19,884<br>57,085|52,475<br>71,028|
|Total income||76,969|76,969|123,503|
|Expenditure<br>on:<br>Charitable<br>activities||50,648|50,648|96,286|
|Total expenditure||50,648|50,648|96,286|
|Net movement<br>in funds||26,321|26,321|27,217|
|Reconciliation<br>offunds:|||||
|Total funds brought<br>forward||275,696|275,696|248,479|
|Net movement<br>in funds||26,321|26,321|27,217|
|||302,017|302,017|275,696|



## 



## 

|||||Total funds|Total funds|
|---|---|---|---|---|---|
|||||2021|2020|
||||Note|||
|Gross income|in the reporting|period||76,969|123,503|
|Less: Total expenditure||||(50,648)|(96,286)|
|||||26,321|27,217|
|Net income for|the reporting|period||||





||||||2021||2020|
|---|---|---|---|---|---|---|---|
||||Note||R|||
|Fixed assets||||||||
|Tangible assets|||||64||86|
||||||64||86|
|Current assets||||||||
|Debtors||||(3,695)||18,111||
|Cash at bank and in hand||||307,881||258,939||
|||||304,186||277,050||
|Creditors: amounts|falling due within one|||||||
|year|||10|(2,233)||(1,440)||
|Net current assets|||||301,953||275,610|
|Total assets less current liabilities|||||302,017||275,696|
|Net assets excluding||pension asset|||302,017||275,696|
|Total net assets|||||302,017||275,696|
|Charity funds||||||||
|Restricted funds|||12|||||
|Unrestricted<br>funds|||12||302,017||275,696|
|Total funds|||||302,017||275,696|





# 

# 

# 

# 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 





## 

## 

|Unrestricted|Total|
|---|---|
|funds|funds|
|2020|2020|
|52,475|52,475|



|||Unrestricted|Total|
|---|---|---|---|
|||funds|funds|
|||2021|2021|
||||E|
|Membership||3,810|3,810|
|Conference|&Events|5,498|5,488|
|Currency difference||1,239|1,239|
|Guidelines||46,538|46,538|
|||57,085|57,085|
|||Unrestricted|Total|
|||funds|funds|
|||2020|2020|
|Membership||2,651|2,651|
|Conference|&Events|29,585|29,585|
|Fundraising|4|496|496|
|Guidelines||38,296|38,296|
|||71,028|71,028|





## 

## 

## 

|||||Unrestricted|Total|
|---|---|---|---|---|---|
|||||funds|funds|
|||||2021|2021|
||||||R|
|Pressure|ulcer|relief|advice|46,343|46,343|
|Research||||4,305|4,305|
|||||Unrestricted|Total|
|||||funds|funds|
|||||2020|2020|
|Pressure|ulcer|relief|advice|84,615|84,615|
|Research||||11,670|11,670|
|Other||||1|1|
|||||96,286|96,286|



## 

|||||Activities|||
|---|---|---|---|---|---|---|
|||||undertaken|Support|Total|
|||||directly|costs|funds|
|||||2021|2021|2021|
|||||R|||
|Pressure|ulcer|relief|advice|2,772|43,571|46,343|
|Research||||4,305||4,305|
|||||7,077|43,571|50,648|





## 

## 

## 

|Analysis|ofex|pendi|ture<br>by activities (conti|nued)|||
|---|---|---|---|---|---|---|
|||||Activities|||
|||||undertaken|Support|Total|
|||||directly|costs|funds|
|||||2020|2020|2020|
|Pressure|ulcer|relief|advice|21,984|62,631|84,615|
|Research||||11,670||11,670|
|||||33,654|62,631|96,286|



## 

||||||2021|2020|
|---|---|---|---|---|---|---|
|Fees payable|to the company's|independent|examiner|for the independent|||
|examination|ofthe company's|annual accounts|||1,440|1,440|



## 

## 

||Office|
|---|---|
||equipment|
||F|
|Cost or valuation||
|At 1 April 2020|209|
|At 31 March 2021|209|





## 

## 

|8.|Tangible fixed asset|s (continued)|||
|---|---|---|---|---|
|||||Office|
|||||equipment|
||Depreciation||||
||At 1 April 2020|||123|
||Charge for the year|||22|
||At 31 March 2021||||
||Net book value||||
||At 31 March 2021||||
||At31March 2020|||86|
|9.|Debtors||||
||||2021|2020|
||||R||
||Due within one year||||
||Trade debtors||(3,695)|18,111|
||||(3,695)|18,111|
|10.|Creditors: Amounts|falling due within one year|||
||||2021|2020|
||Accruals and deferred|income|2233|1,440|





## 

## 



## 

## 

|Statement o|ff|unds - current year|||||
|---|---|---|---|---|---|---|
|||||||Balance at|
||||Balance at 1|||31 March|
||||April 2020|Income|Expenditure|2021|
||||R||R||
|Unrestricted|funds||||||
|General Funds||- all funds|275,696|123,503|(96,286)|302,913|
|General Funds||1||(46,534)|45,638|(896)|
||||275,696|76,969|(50,648)|302,017|






## 




## 

## 

## 

|Analysis ofnet assets between funds - current ye|ar||
|---|---|---|
||Unrestricted|Total|
||funds|funds|
||2021|2021|
||E||
|Tangible fixed assets|64|64|
|Current assets|304,185|304,165|
|Creditors due within one year|(2,233)|(2,233)|
|Difference|1|(1)|
|Total|302,017|302,017|



## 

|Analysis|ofn|et assets between funds - prior year|||
|---|---|---|---|---|
||||Unrestricted|Total|
||||funds|funds|
||||2020|2020|
|Tangible|fixed|assets|86|86|
|Current|assets||277,050|277,050|
|Creditors|due|within one year|(1,440)|(1,440)|
|Total|||275696|275696|



##